Indications & Dose:
Primary hypercholesterolaemia, or combined(mixed) hyperlipidaemia in patients who have not responded adequately to diet and other appropriate measures
Adult: 10–20 mg once daily, then increased if necessary up to 80 mg once daily, adjusted at intervals of at least 4 weeks, dose to be taken at night; 80 mg dose only for those with severe hypercholesterolaemia and at high risk of cardiovascular complications
Homozygous familial hypercholesterolaemia in patients who have not responded adequately to diet and other appropriate measures
Adult: Initially 40 mg once daily, then increased if necessary up to 80 mg once daily, adjusted at intervals of at least 4 weeks, dose to be taken at night; 80 mg dose only for those with severe hypercholesterolaemia and at high risk of cardiovascular complications
Prevention of cardiovascular events in patients with atherosclerotic cardiovascular disease or diabetes mellitus
% BY MOUTH
Adult: Initially 20–40 mg once daily, increased if necessary up to 80 mg once daily, adjusted at intervals of at least 4 weeks, dose to be taken at night; 80 mg dose only for those with severe hypercholesterolaemia and at high risk of cardiovascular complications
DOSE ADJUSTMENTS DUE TO INTERACTIONS
Max. 10 mg daily with concomitant bezafibrate or ciprofibrate. Max. 20 mg daily with concomitant amiodarone, verapamil, diltiazem, amlodipine, or ranolazine. Max. 40 mg daily with concomitant lomitapide.
Contraindications:
Active liver disease, Pregnancy & breast feeding
Side Effects:
CNS: Dizziness, headache, insomnia, memory loss, peripheral neuropathy, tremor, vertigo
GI: Abdominal pain, constipation, diarrhea, dyspepsia, flatus, heartburn, liver dysfunction, nausea, pancreatitis, vomiting
GU: Erectile dysfunction, gynecomastia, loss of libido
HEME: Eosinophilia, hemolytic anemia, leukopenia, thrombocytopenia
MS: Muscle cramps, myalgia, myositis, rhabdomyolysis
SKIN: Alopecia, pruritus, rash, Stevens-Jhonson syndrome
Cautions:
Precautions:
Past liver disease, alcoholism, severe acute infections, trauma, hypotension, uncontrolled seizure disorders, severe metabolic disorders, electrolyte imbalances
Interaction:
Drugs
Azole antifungals (fluconazole, itraconazole, ketoconazole, miconazole): Increased simvastatin levels via inhibition of metabolism with increased risk of rhabdomyolysis
Cbolestyramine, colestipol: Reduced bioBrands Available with Cost of simvastatin
Cyclosporine: Concomitant administration increases risk of severe myopathy or rhabdomyolysis
Danazol: Inhibition of metabolism (CYP3A4) fight to yield increased simvastatin levels with increased risk of rhabdomyolysis
Fluoxetine: Inhibits CYP3A4 hepatic metabolism with risk of rhabdomyolysis
Gemfibrozil: Small increased risk of myopathy with combination, especially at high doses of statin
Isradipine: Isradipine probably decreases simvastatin (like lovastatin) plasma concentrations minimally
Macrolide antibiotics (clarithromycin, erythromycin, troleandomycin): Increased simvastatin levels via inhibition of metabolism with increased risk of rhabdomyolysis
Nefazodone: Inhibit CYP3A4 hepatic metabolism (like lovastatin) with risk of rhabdomyolysis
Niacin: Concomitant administration increases risk of severe myopathy or rhabdomyolysis
Warfarin: Addition of simvastalin may increase hypoprothrombinemic response to warfarin via inhibition of metabolism (CYP2C9)
Warnings:
Adverse Effects:
Lactations:
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team